No patient would choose a treatment that requires hours and hours of IV infusion after being laid waste by hours and hours of IV chemo if there was a commensurate swish and spit treatment.
I'm feeling good about a deal too. Interested to see the terms if we do. Good chance it will be for more than just the OM application, may be for entire B (entire HDP-M platform possible too, but less likely).
Market Data 
Markets 
AI
